A detailed history of Bartlett & Co. Wealth Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Bartlett & Co. Wealth Management LLC holds 1,410 shares of AZN stock, worth $95,034. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,410
Previous 1,579 10.7%
Holding current value
$95,034
Previous $123 Million 10.79%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$76.67 - $87.62 $12,957 - $14,807
-169 Reduced 10.7%
1,410 $110 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $48,707 - $54,523
787 Added 99.37%
1,579 $106 Million
Q2 2023

Feb 14, 2024

BUY
$69.91 - $75.81 $11,814 - $12,811
169 Added 27.13%
792 $56.7 Million
Q3 2021

Feb 13, 2024

BUY
$55.56 - $60.79 $1,500 - $1,641
27 Added 4.53%
623 $37.4 Million
Q4 2020

Feb 13, 2024

BUY
$48.52 - $58.02 $2,086 - $2,494
43 Added 7.78%
596 $29.8 Million
Q3 2020

Feb 13, 2024

BUY
$53.07 - $61.1 $5,307 - $6,110
100 Added 22.08%
553 $30.3 Million
Q2 2020

Feb 13, 2024

SELL
$43.1 - $55.31 $1,034 - $1,327
-24 Reduced 5.03%
453 $24 Million
Q1 2020

Feb 13, 2024

BUY
$37.79 - $51.33 $906 - $1,231
24 Added 5.3%
477 $21.3 Million
Q3 2019

Feb 13, 2024

BUY
$40.12 - $45.47 $18,174 - $20,597
453 New
453 $20.2 Million
Q2 2019

Feb 13, 2024

SELL
$37.28 - $41.68 $2,423 - $2,709
-65 Closed
0 $0
Q1 2019

Feb 13, 2024

SELL
$35.49 - $43.02 $54,477 - $66,035
-1,535 Reduced 95.94%
65 $2.63 Million
Q3 2018

Feb 13, 2024

BUY
$34.76 - $39.72 $55,616 - $63,552
1,600 New
1,600 $63.3 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $209B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Bartlett & Co. Wealth Management LLC Portfolio

Follow Bartlett & Co. Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.